A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.
A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.
A controversial Boston University laboratory could open by the end of the month, but at a lower safety rating than originally planned.
A German ethics council weighs in on the discussion about the use of human-animal chimeras in research.
Pharmacovigilance must keep pace with global distribution of drugs in resource-limited settings.
Ten years after an investigative report found that 10 papers on sudden infant death syndrome (SIDS) were “flawed,” only one has been pulled from the literature.
Waste from pharmaceutical factories is finding its way to the world’s waterways, and affecting the sexual attributes of local fish.
The United Kingdom is revamping its intellectual property laws for published research.
A new report says the FDA’s current oversight of medical devices is inadequate and should be revamped.
A new study suggests that new cancer treatments generally go on sale in the United States before they reach European markets
A snapshot of the most highly ranked articles in molecular biology, from Faculty of 1000